Related Experiment Video
Updated: Jul 10, 2025
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Joining Forces: The Combined Application of Therapeutic Viruses and Nanomaterials in Cancer Therapy
Hongyu Li1,2, Yunhuan Zhu1, Xin Wang3
1Shulan International Medical College, Zhejiang Shuren University, Hangzhou 310015, China.
Abstract:
Cancer, on a global scale, presents a monumental challenge to our healthcare systems, posing a significant threat to human health. Despite the considerable progress we have made in the diagnosis and treatment of cancer, realizing precision cancer therapy, reducing side effects, and enhancing efficacy remain daunting tasks. Fortunately, the emergence of therapeutic viruses and nanomaterials provides new possibilities for tackling these issues. Therapeutic viruses possess the ability to accurately locate and attack tumor cells, while nanomaterials serve as efficient drug carriers, delivering medication precisely to tumor tissues. The synergy of these two elements has led to a novel approach to cancer treatment-the combination of therapeutic viruses and nanomaterials. This advantageous combination has overcome the limitations associated with the side effects of oncolytic viruses and the insufficient tumoricidal capacity of nanomedicines, enabling the oncolytic viruses to more effectively breach the tumor's immune barrier. It focuses on the lesion site and even allows for real-time monitoring of the distribution of therapeutic viruses and drug release, achieving a synergistic effect. This article comprehensively explores the application of therapeutic viruses and nanomaterials in tumor treatment, dissecting their working mechanisms, and integrating the latest scientific advancements to predict future development trends. This approach, which combines viral therapy with the application of nanomaterials, represents an innovative and more effective treatment strategy, offering new perspectives in the field of tumor therapy.
Insights
Combining therapeutic viruses and nanomaterials offers a novel cancer therapy approach. This synergy enhances precision, reduces side effects, and improves treatment efficacy against tumors.
Area of Science:
- Oncology
- Nanomedicine
- Virology
Background:
- Cancer remains a significant global health challenge, with current treatments facing limitations in precision, side effect management, and efficacy.
- Therapeutic viruses and nanomaterials show promise individually for cancer treatment.
- Combining these modalities presents a novel strategy to overcome existing therapeutic hurdles.
Purpose of the Study:
- To explore the application of therapeutic viruses combined with nanomaterials for tumor treatment.
- To dissect the mechanisms of action for this combined therapeutic approach.
- To integrate recent advancements and predict future trends in viral and nanomaterial-based cancer therapy.
Main Methods:
- Review and synthesis of current scientific literature on therapeutic viruses and nanomaterials in oncology.
- Analysis of the synergistic mechanisms between oncolytic viruses and nanocarriers.
- Discussion of advancements in targeting, drug delivery, and real-time monitoring.
Main Results:
- The combination of therapeutic viruses and nanomaterials enhances tumor cell targeting and destruction.
- This synergistic approach mitigates side effects associated with traditional oncolytic virotherapy.
- Nanomaterials improve the delivery and efficacy of oncolytic viruses, overcoming tumor immune barriers.
- Real-time monitoring of viral distribution and drug release is achievable.
Conclusions:
- The combination of therapeutic viruses and nanomaterials represents an innovative and effective strategy for cancer treatment.
- This approach offers improved precision, reduced toxicity, and enhanced anti-tumor activity.
- Future developments hold significant promise for advancing precision cancer therapy.
Related Concept Videos
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...